Skinvisible (SKVI) Common Equity (2016 - 2025)
Historic Common Equity for Skinvisible (SKVI) over the last 16 years, with Q3 2025 value amounting to -$10.0 million.
- Skinvisible's Common Equity fell 138.8% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.0 million, marking a year-over-year decrease of 138.8%. This contributed to the annual value of -$9.2 million for FY2024, which is 222.19% down from last year.
- Per Skinvisible's latest filing, its Common Equity stood at -$10.0 million for Q3 2025, which was down 138.8% from -$9.8 million recorded in Q2 2025.
- Skinvisible's Common Equity's 5-year high stood at -$4.9 million during Q1 2021, with a 5-year trough of -$10.0 million in Q3 2025.
- For the 5-year period, Skinvisible's Common Equity averaged around -$7.7 million, with its median value being -$8.4 million (2023).
- As far as peak fluctuations go, Skinvisible's Common Equity plummeted by 4485.47% in 2023, and later plummeted by 138.8% in 2025.
- Quarter analysis of 5 years shows Skinvisible's Common Equity stood at -$5.4 million in 2021, then fell by 22.62% to -$6.6 million in 2022, then crashed by 35.88% to -$9.0 million in 2023, then fell by 2.22% to -$9.2 million in 2024, then fell by 8.47% to -$10.0 million in 2025.
- Its Common Equity was -$10.0 million in Q3 2025, compared to -$9.8 million in Q2 2025 and -$9.5 million in Q1 2025.